ACOG vs AWHONN Guideline Navigator

ACOG vs AWHONN
Labor Guideline Navigator

Where professional guidelines agree, where they diverge, and why it matters at the bedside

The Critical Difference

AWHONN recommends treating tachysystole regardless of fetal heart rate status. ACOG only triggers oxytocin reduction for category II or III tracings. This means under ACOG guidance, the fetus must show signs of compromise before excessive uterine activity is addressed. AWHONN's approach is preventive: fix the contractions before the FHR deteriorates. The fetus should not have to declare distress for the team to act.

Source Publication

1 Donelan EA, Morgan A, Densmore J, Murray K, Hanlon Taub M, Martel M, et al. Professional guideline discrepancies as a barrier to labor progress and teamwork. Obstet Gynecol 2026;147:313-21. Primary Source
Systematic comparison of ACOG and AWHONN guidance across FHR, uterine activity, oxytocin, and labor management
2 Simpson KR. Cervical ripening and labor induction and augmentation, 5th ed. J Obstet Gynecol Neonatal Nurs 2020;49:S1-41. AWHONN
3 First and second stage labor management. ACOG Clinical Practice Guideline No. 8. Obstet Gynecol 2024;143:144-62. ACOG
4 Intrapartum fetal heart rate monitoring: interpretation and management. ACOG Clinical Practice Guideline No. 10. Obstet Gynecol 2025;146:583-99. ACOG
5 Lyndon A, Wisner K, eds. Fetal heart monitoring: principles and practices. 6th ed. Kendall Hunt; 2021. AWHONN

The Preventive vs Reactive Divide

The single most important discrepancy: AWHONN treats tachysystole irrespective of FHR category. ACOG intervenes only when the tracing is already category II or III. One approach prevents fetal compromise. The other waits for it.

1
Critical Discrepancy
14
Areas of Disagreement
8
Areas of Agreement
Show:
Standard NICHD Nomenclature Similar
ACOG
Endorses NICHD FHR interpretation guidelines (CPG No. 10).
AWHONN
Endorses NICHD FHR interpretation guidelines (Simpson 2020).

Bedside Impact

Both organizations use the same three-tier classification system (Categories I, II, III). No conflict expected here.

EFM and Maternal/Neonatal Outcomes Similar
ACOG
Continuous EFM associated with increased cesarean (RR 1.63) and operative vaginal delivery (RR 1.15) without reduction in perinatal death or cerebral palsy.
AWHONN
Routine EFM linked to increases in operative birth rates without accompanying decrease in perinatal mortality or childhood morbidity.

Bedside Impact

Both acknowledge EFM has not improved neonatal outcomes. Yet EFM remains universal, and interpreting tracings remains a primary source of conflict.

Intermittent Auscultation Similar
ACOG
Facilities should consider protocols and training for intermittent auscultation for low-risk women.
AWHONN
Increasing availability and use of IA recommended as one component to reduce primary cesarean rate and promote vaginal birth.
Category II FHR Algorithm Specificity Different
ACOG
General algorithm example (CPG No. 10, Fig. 1). Less prescriptive for next steps.
AWHONN
Features specific algorithms (Clark's and Shields') across multiple texts and courses. More prescriptive stepwise management.

Bedside Impact

Nurses trained on specific AWHONN algorithms may feel physicians are not following protocol. Physicians may feel nurses are being too rigid. The mismatch in specificity creates friction over who decides the "next step."

Inducing with Abnormal Fetal Testing Different
ACOG
Delivery of a fetus with abnormal test results may often be attempted by induction of labor with continuous monitoring.
AWHONN
FHR should be normal before oxytocin is administered.

Bedside Impact

A nurse following AWHONN may refuse to start oxytocin if the tracing is not category I. The physician may have determined that the clinical indication for delivery outweighs a category II tracing. Neither is "wrong" by their respective guidelines.

Maternal Oxygen for FHR Changes Different
ACOG
Recommends against routine maternal oxygen for category II/III tracings in absence of maternal hypoxia. Strong recommendation, high-quality evidence.
AWHONN
Maternal oxygen therapy for 15-30 min appears reasonable in selected cases when other intrauterine resuscitation measures have not been successful.

Bedside Impact

When a nurse reaches for the oxygen mask for intrauterine resuscitation, they are following AWHONN guidance. The physician who questions this is following ACOG's strong recommendation against it. Both cite evidence.

Definition of Tachysystole Similar
ACOG
Endorses NICHD definitions of tachysystole.
AWHONN
Endorses NICHD definitions of tachysystole.
Additional Criteria for Excessive Uterine Activity Different
ACOG
No mention of resting tone, relaxation time, or contraction duration criteria beyond tachysystole.
AWHONN
Defines additional criteria: contractions lasting ≥2 min, resting tone >25 mmHg via IUPC, relaxation time <60 sec in first stage, <45 sec in second stage.

Bedside Impact

AWHONN-trained nurses monitor uterine activity parameters that ACOG does not address at all. A nurse may flag elevated resting tone or short relaxation time; the physician's guidelines simply do not recognize these parameters.

Misoprostol with Existing Contractions Different
ACOG
Discusses tachysystole risk with misoprostol and offers dosing regimens to decrease this risk. Does not recommend against use with existing contractions.
AWHONN
Consider delaying or avoiding misoprostol when a patient has frequent low-amplitude painless contractions, or ≥2 painful contractions per 10 min, particularly if another uterotonic has been given.

Bedside Impact

This is exactly the conflict in the opening case. The nurse raised concern about misoprostol with the ripening balloon because AWHONN advises caution with existing contractions. ACOG does not address this specific scenario.

🔴 Tachysystole with Category I FHR Critical Discrepancy
⚠ ACOG
No mention of management of tachysystole with a category I tracing. Only addresses tachysystole management in the context of category II or III tracings (decrease or discontinue oxytocin).
✓ AWHONN
"Waiting until the FHR is indeterminate or abnormal to treat tachysystole is not consistent with fetal safety." Tachysystole should be treated regardless of FHR category.

Why This Is the Central Issue

ACOG's framework is reactive: the uterus can be hyperstimulated as long as the fetus appears to be tolerating it. The fetal heart rate must deteriorate before the team acts.

AWHONN's framework is preventive: excessive uterine activity is a problem in itself, independent of what the monitor shows. Treat the contractions before the fetus shows compromise.

This is not a minor philosophical distinction. A category I tracing during tachysystole means the fetus is compensating right now. It does not mean the fetus will continue to compensate. By the time the tracing changes, the window for simple intervention (reducing oxytocin) may have narrowed considerably. The AWHONN position aligns with preventive physiology: do not wait for decompensation to intervene.

Tachysystole with Category II/III FHR Similar
ACOG
Decrease or discontinue oxytocin.
AWHONN
Decrease or discontinue oxytocin.

Bedside Impact

Agreement here, but only because the FHR has already declared a problem. The disagreement that matters is what to do before the tracing deteriorates.

Dosing Protocols Different
ACOG
No significant differences in maternal or neonatal outcomes with different dosing regimens. Either low-dose or high-dose is reasonable.
AWHONN
Either approach is acceptable, but emphasizes "the lowest amount needed" and recommends starting at 1-2 mU/min with 1-2 mU/min increases every 30-40 min.

Bedside Impact

A physician ordering a high-dose protocol is within ACOG guidance. A nurse accustomed to AWHONN's emphasis on "lowest amount" may view higher doses as unsafe rather than as an equally supported approach.

Maximum Dosing Different
ACOG
A maximum dose of oxytocin has not been established.
AWHONN
Increasing beyond 20 mU/min requires bedside evaluation by physician or CNM and should be considered only in unusual clinical situations.

Bedside Impact

In the opening case, the patient was on 22 mU/min with inadequate contractions. By AWHONN standards, this was already in "unusual" territory. By ACOG standards, there is no established ceiling. This is a common flashpoint.

Oxytocin in Active Labor Different
ACOG
Further research needed on whether cessation after active phase reduces cesarean rate. No recommendation to decrease.
AWHONN
Once active labor is established, oxytocin should be decreased or discontinued to prevent receptor downregulation, especially in prolonged inductions.

Bedside Impact

A nurse who turns down oxytocin once active labor is reached is following AWHONN guidance on receptor downregulation. A physician who wants to maintain or increase oxytocin for inadequate contractions in active labor is following ACOG. Both are "right" by their respective standards.

Dysfunctional Contraction Patterns Different
ACOG
No recommendation for oxytocin discontinuation in dysfunctional patterns.
AWHONN
Calls it a "long-standing myth" that abnormal uterine activity is best treated with oxytocin increases. Recommends reducing or discontinuing until normal activity returns (receptor desensitization rationale).

Bedside Impact

When contractions are coupling, stacking, or irregular, the physician's instinct (increase oxytocin to establish a normal pattern) directly opposes the nurse's training (decrease because the receptors are overwhelmed). This conflict plays out daily on labor units nationwide.

Active Phase Definition (6 cm) Similar
ACOG
6 cm dilation = start of active phase.
AWHONN
6 cm = threshold for active phase.
Active Phase Arrest Criteria Similar
ACOG
≥6 cm + ruptured membranes + no progress despite 4 hr adequate activity or 6 hr inadequate activity with oxytocin.
AWHONN
≥6 cm + ruptured membranes + no progress despite 4 hr adequate activity or ≥6 hr oxytocin with inadequate activity and no cervical change.
Dual Cervical Ripening Different
ACOG
Suggests combination of pharmacologic and mechanical methods to shorten admission-to-delivery time (CPG No. 9).
AWHONN
Recognizes various methods are used. No mention of combination methods.

Bedside Impact

A physician ordering simultaneous balloon + misoprostol is following ACOG. The nurse may have no AWHONN guidance to support this and may raise safety concerns, particularly about tachysystole risk.

Amniotomy Different
ACOG
Recommends amniotomy for all patients undergoing augmentation or induction to reduce labor duration.
AWHONN
Mentions amniotomy only as a tool when abnormal progress is diagnosed.

Bedside Impact

The opening case: the physician recommended early AROM, the nurse requested delay. Under ACOG, amniotomy is standard. Under AWHONN, it is reserved for arrested progress. This delay contributed to the prolonged labor.

Initiation of Pushing Different
ACOG
Recommends pushing commence when complete cervical dilation is achieved.
AWHONN
Consider delaying pushing until maternal urge to push (up to 2 hr nulliparous, 1 hr multiparous). Delayed pushing can promote fetal wellbeing.

Bedside Impact

Patient is complete; physician says start pushing. Nurse says wait for the urge. This plays out on every labor unit, every day. Both are following their respective guidelines.

FHR Changes in Second Stage Different
ACOG
References "modification of cadence of maternal expulsive efforts" as resuscitative strategy, but acknowledges this is expert opinion without quality data.
AWHONN
Recommends reducing pushing to every other or every third contraction for category II FHR. Presents this as effective for minimizing progressive fetal oxygen desaturation. Based on a single RCT of 45 women (Simpson 2005).

Bedside Impact

AWHONN presents intermittent pushing as evidence-based without grading the evidence. ACOG acknowledges it lacks quality data. A nurse limiting pushing to every third contraction may frustrate a physician who sees no evidence basis and fears prolonging the second stage.

Neuraxial Analgesia Different
ACOG
Regional techniques provide pain relief with minimal maternal and neonatal adverse effects.
AWHONN
Highlights risks: hypotension (~10%), fever (~30%), FHR decelerations/bradycardia (17-42%). Note: the 17-42% figure was miscited from an ACOG bulletin about uterine resting tone, not FHR.

Bedside Impact

The framing differs: ACOG presents epidurals as largely benign; AWHONN highlights complications. A nurse trained on AWHONN's complication rates may view epidurals more cautiously. The miscitation of the 17-42% FHR figure is particularly problematic, as it inflates perceived risk.

Elective Induction / ARRIVE Trial Different
ACOG
Shared decision-making for induction at/beyond 39 weeks. Discusses resource and equity considerations.
AWHONN
Emphasizes ARRIVE confirmed it is "safe to await spontaneous labor." Warns of potential increase in elective induction and "escalation of the medicalization of childbirth."

Bedside Impact

ACOG and AWHONN draw different conclusions from the same trial. ACOG focuses on the reduced cesarean rate with induction. AWHONN focuses on validating expectant management and warns against overmedicalization. This sets the stage for philosophical conflict about the role of intervention.

Outpatient Cervical Ripening Different
ACOG
Outpatient cervical ripening is safe and effective for reducing admission-to-delivery time in low-risk patients.
AWHONN
Evidence from US RCTs is needed before outpatient cervical ripening can be considered.